Federal government agency
National Cancer Institute (NCI) Grants
20 open National Cancer Institute (NCI) grants accepting applications right now. Historical giving: 9 grants totaling $7.5M.
Want AI mission-fit scoring on National Cancer Institute (NCI) opportunities? Start a free trial.
Open National Cancer Institute (NCI) grants
NCI SBIR Phase IIB Bridge Award
Up to $4.5MopenNCI SBIR Phase IIB Bridge Award is sponsored by National Cancer Institute (NCI). Supports the next stage of development for federally funded SBIR Phas...
cancer_researchbiomedical_researchhealth_disparitiescancerbiotechNCI Outstanding Investigator Award (R35)
Up to $600KopenNCI Outstanding Investigator Award (R35) is a grant from the National Cancer Institute (NCI) that supports investigators with outstanding cancer resea...
cancer_researchbiomedical_researchhealth_disparitiescanceroncologyMechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
Up to $500KopenMechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) is sponsored by National Cancer Institute (NCI). Funds resear...
cancer_researchpublic_healthclinical_researchcancer riskbariatric surgeryNational Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Up to $500KopenNational Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) is spo...
cancer_researchclinical_researchprecision_medicinebiomedical_researchcancerExploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
Up to $275KDeadline: Jan 7, 2028openExploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI). This...
biomedical_researchcancer_researchclinical_researchbioengineeringcancer detectionPA-25-253: Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Up to $275KopenPA-25-253: Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) is sponsored by National Cancer Institute (NCI).
cancer_researchpublic_healthhealth_disparitiesclinical_researchcancer controlSecondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
Up to $275KopenSecondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) is sponsored by Na...
cancer_researchpublic_healthbiomedical_researchcancerepidemiologyNCI Mentored Research Scientist Development Award (K01 - Independent Clinical Trial Required)
Up to $150KopenNCI Mentored Research Scientist Development Award (K01 - Independent Clinical Trial Required) is sponsored by National Cancer Institute (NCI). Provide...
cancer_researchpublic_healthbiomedical_researchhealth_disparitiescancerHigh-Risk, High-Reward Immunology Innovation (ExCITe)
Deadline: Nov 17, 2026openHigh-Risk, High-Reward Immunology Innovation (ExCITe) is a grant from the National Cancer Institute (NCI) that funds innovative, exploratory cancer im...
health_disparitiesinfectious_diseasecancer_researchimmunologyimmune regulationAcademic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01)
Deadline: Jan 7, 2027openAcademic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01) is sponsored by National Cancer Institute ...
cancer_researchclinical_researchbiomedical_researchin vivo imagingcancer imagingNCI - Notice of Special Interest (NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention and Cancer Interception Research
Deadline: Jan 8, 2027openNCI - Notice of Special Interest (NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention an...
cancer_researchnutritionbiomedical_researchpublic_healthbiomarkersThe NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
Deadline: Feb 18, 2027openThe NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional) is sponsored by ...
cancer_researchpublic_healthcommunity_developmentclinical_researchcareer developmentExploratory/Developmental or Research Project Grants for Etiologic and Mechanistic Research on Early-Onset Cancers (R21/R01 Clinical Trial Optional)
Deadline: Mar 10, 2027openExploratory/Developmental or Research Project Grants for Etiologic and Mechanistic Research on Early-Onset Cancers (R21/R01 Clinical Trial Optional) i...
cancer_researchbiomedical_researchclinical_researchearly-onset canceretiologyExploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Deadline: Jan 7, 2028openExploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) is sponsored by National Cancer Institute (NCI). This op...
biomedical_researchcancer_researchclinical_researchai_healthcarebioengineeringResearch on Rare Cancers Across the Cancer Control Continuum
Deadline: Feb 20, 2028openResearch on Rare Cancers Across the Cancer Control Continuum is sponsored by National Cancer Institute (NCI). Encourages applications to accelerate re...
cancer_researchclinical_researchbiomedical_researchpublic_healthhealth_disparitiesAdvancing Nanotechnology Research to Improve Diagnosis and Treatment Options
Deadline: Mar 10, 2028openAdvancing Nanotechnology Research to Improve Diagnosis and Treatment Options is sponsored by National Cancer Institute (NCI). This program supports re...
cancer_researchmaterials_sciencebiomedical_researchclinical_researchbiotechnologyCancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Deadline: Sep 26, 2028openCancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers is a grant from the National Cancer Institute that funds support for three type...
health_disparitiescancer_researchpublic_healthcanceroncologyResearch Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
Deadline: Jul 5, 2029openResearch Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI). This fu...
cancer_researchpublic_healthclinical_researchbiomedical_researchcancer epidemiologyNCI Small Business Innovation Research (SBIR) Program
openNCI Small Business Innovation Research (SBIR) Program is sponsored by National Cancer Institute (NCI). Provides funding for small businesses to develo...
cancer_researchbiomedical_researchprecision_medicinesmall_businesscancer therapyAI in Cancer Research
openAI in Cancer Research is sponsored by National Cancer Institute (NCI). Supports the development of artificial intelligence tools and models for cancer...
artificial_intelligencecancer_researchbiomedical_researchai_healthcaredata_science
What National Cancer Institute (NCI) funds
Top program areas based on GrantMind's analysis of recent National Cancer Institute (NCI) awards:
How to apply for National Cancer Institute (NCI) grants
Most National Cancer Institute (NCI) applications require: an organizational profile with mission and programs, a project proposal aligned with the funder's stated priorities, a project budget, and supporting attachments (IRS determination letter, board list, recent financials). Federal applicants additionally need a SAM.gov UEI and an active Grants.gov account.
Read: How to write a Letter of Inquiry that gets you invited to applyFind every National Cancer Institute (NCI) opportunity matched to your mission
Not sure where to start? Paste your website and get your three best-matched grants free — no account needed. Or start a free trial for AI mission-fit scoring across National Cancer Institute (NCI) and 100,000+ other active funders, with proposals tuned to each funder's stated priorities.
Match: no account needed · Trial: no credit card required